FDA NDC
Fondaparinux Sodium
This name is from the loaded FDA file.
Source: FDA NDC Directory, live from openFDA. Publisher page
- NDC
- 67457-583
- Proprietary name
- Fondaparinux Sodium
- Nonproprietary name
- fondaparinux sodium
- Labeler
- Mylan Institutional LLC
- Dosage form
- INJECTION, SOLUTION
- Strength
- 5 mg/.4mL
Run it in Rivvi
Which 2027 plans near you dropped or restricted fondaparinux sodium?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan, from the CMS Part D files.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.